PRAXIS PRECISION MEDICINES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum

PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 87.30% for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-23.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2020-11-23

PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2020-09-30 was 87.30%.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month
2020-09-30	87.30% 10-Q · filed 2020-11-23	88.11% 10-Q · filed 2020-11-23

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
Alkermes plc. (ALKS)		$6.844B	132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Liquidia Corp (LQDA)	United States	$6.347B	51.23